National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 Clinical Management by E. Nicastri, N. Petrosillo, L. Lepore, A. Mondi, T. Ascoli Marchetti, D'Offizi G., F. Palmieri, L. Marchioni, S. Murachelli, G. Ippolito, A. Antinori, INMI COVID-19 Treatment Group (ICOTREG)

Connect to this object online.

Durable Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI Studies by P. Cahn, J. Sierra Madero, J. Arribas, A. Antinori, R. Ortiz, A. Clarke, C. Hung, J. Rockstroh, P. Girard, J. Sievers, C. Man, R. Urbaityte, M. Underwood, A. Tenorio, K. Pappa, B. Wynne, M. Gartland, M. Aboud, J. van Wyk, K. Smith, Y. El-Bahy

Connect to this object online.

O4 Early start of antiretroviral therapy (ART) during primary HIV infection (PHI) is associated with faster optimal immunological recovery: results of Italian Network of ACuTe HIV... by A. Muscatello, A. Bandera, M. Fabbiani, I. De Benedetto, A. Ammassari, A. Antinori, A. Calcagno, B.M. Celesia, A. Cingolani, G. d'Ettorre, A. Di Biagio, E. Focà, E. Girardi, R. Gulminetti, G. Madeddu, G. Marchetti, C. Mussini, S. Nozza, G. Orofino, D. Ripamonti, S. Rusconi, G. Tambussi, A. Gori

Connect to this object online.